Industry
Featured experience
Novo Nordisk acquisition of certain Catalent sites from Novo Holdings
We are advising Novo Nordisk on the acquisition
AbbVie $15 billion senior notes offering
The investment-grade offering comprised seven tranches
Auna $360 million U.S. IPO
We advised Auna on its U.S. IPO and NYSE listing
Trial victory in patent infringement case for Magnolia Medical Technologies
We served as lead trial counsel for Magnolia Medical in an action against its sole competitor
PracticeTek merger with Integrated Practice Solutions and related financing
We advised Lightyear Capital and PracticeTek on the transaction to form a leading U.S. retail healthcare solutions provider
Walgreens Boots Alliance registered variable prepaid forward transactions
The transactions cover up to 10,500,000 shares of AmerisourceBergen stock
Mallinckrodt prepackaged chapter 11 filing and restructuring support agreement
We are advising an ad hoc group of first-lien noteholders
Abcam $5.7 billion acquisition by Danaher
We advised financial advisers to Abcam on the transaction
TRYT ¥55.2 billion IPO
The shares are listed on the Tokyo Stock Exchange
Johnson & Johnson splits off Kenvue
This is the largest split-off transaction ever done
AN2 Therapeutics $70 million follow-on offering
The shares are listed on the Nasdaq Global Select Market
RAPT Therapeutics $150 million at-the-market offering
The shares are listed on the Nasdaq Global Market
Shockwave Medical $750 million convertible senior notes offering
The 1% convertible notes are due 2028
Cano Health amendment and covenant waiver for side-car credit facility
We advised Rubicon Founders in connection with the transaction